These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9158033)

  • 21. Autoimmune destruction of islet grafts in the NOD mouse is resistant to 15-deoxyspergualin but sensitive to anti-CD4 antibody.
    Stegall MD; Loberman Z; Ostrowska A; Coulombe M; Gill RG
    J Surg Res; 1996 Aug; 64(2):156-60. PubMed ID: 8812627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ICAM-1 antisense oligodeoxynucleotide improves islet allograft survival and function.
    Katz SM; Bennett F; Stecker K; Clark JH; Pham T; Wang ME; Kahan BD; Stepkowski SM
    Cell Transplant; 2000; 9(6):817-28. PubMed ID: 11202568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models.
    Rothstein DM; Livak MF; Kishimoto K; Ariyan C; Qian HY; Fecteau S; Sho M; Deng S; Zheng XX; Sayegh MH; Basadonna GP
    J Immunol; 2001 Jan; 166(1):322-9. PubMed ID: 11123308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody.
    Uppaluri R; Sheehan KC; Wang L; Bui JD; Brotman JJ; Lu B; Gerard C; Hancock WW; Schreiber RD
    Transplantation; 2008 Jul; 86(1):137-47. PubMed ID: 18622291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anergic T cells generated in vitro suppress rejection response to islet allografts.
    Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
    Transplantation; 2000 May; 69(10):2144-8. PubMed ID: 10852614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged survival of allogeneic islet grafts in NOD mice treated with a combination of anti-CD45RB and anti-CD154 antibodies.
    Molano RD; Berney T; Pileggi A; Ricordi C; Burkly L; Rothstein D; Basadonna G; Inverardi L
    Transplant Proc; 2001; 33(1-2):248-9. PubMed ID: 11266802
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
    Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
    Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154.
    Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Ricordi C; Rothstein DM; Basadonna GP; Inverardi L
    Diabetes; 2003 Apr; 52(4):957-64. PubMed ID: 12663467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
    Demirci G; Strom TB; Li XC
    J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolongation of allograft survival by administration of anti-CD45RB monoclonal antibody is due to alteration of CD45RBhi: CD45RBlo T-cell proportions.
    Luke PP; Deng JP; Lian D; O'Connell PJ; Garcia B; Jevnikar AM; Zhong R
    Am J Transplant; 2006 Sep; 6(9):2023-34. PubMed ID: 16827791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolongation of rat islet allograft survival by treatment with monoclonal antibodies against VLA-4 and LFA-1.
    Yang H; Issekutz TB; Wright JR
    Transplantation; 1995 Jul; 60(1):71-6. PubMed ID: 7624946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
    Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
    Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD45RB-targeting strategies for promoting long-term allograft survival and preventingchronic allograft vasculopathy.
    Sho M; Harada H; Rothstein DM; Sayegh MH
    Transplantation; 2003 Apr; 75(8):1142-6. PubMed ID: 12717193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CTLA-4 up-regulation plays a role in tolerance mediated by CD45.
    Fecteau S; Basadonna GP; Freitas A; Ariyan C; Sayegh MH; Rothstein DM
    Nat Immunol; 2001 Jan; 2(1):58-63. PubMed ID: 11135579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
    Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
    Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts.
    Takeda Y; Gotoh M; Dono K; Nishihara M; Grochowiecki T; Kimura F; Yoshida T; Ohta Y; Ota H; Ohzato H; Umeshita K; Takeda T; Matsuura N; Sakon M; Kayagaki N; Yagita H; Okumura K; Miyasaka M; Monden M
    Diabetologia; 1998 Mar; 41(3):315-21. PubMed ID: 9541172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged survival of rat islet xenografts in mice after CD45RB monotherapy.
    Visser L; Poppema S; de Haan B; Klok P; van der Leij J; van den Berg A; de Vos P
    Transplantation; 2004 Feb; 77(3):386-91. PubMed ID: 14966412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of CD4+ and CD8+ cells in islet allo- and xeno-graft rejection.
    Gotoh M; Monden M; Yamamoto H; Kawai M; Ichikawa T; Mori T; Uenaka A; Nakayama E
    Horm Metab Res Suppl; 1990; 25():173-6. PubMed ID: 1982441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.